You just read:

Milestone Pharmaceuticals Announces Topline Results from First-of-its-kind Phase 3 NODE-301 Trial of Etripamil for At-home Acute PSVT Treatment

News provided by

Milestone Pharmaceuticals, Inc.

Mar 23, 2020, 16:05 ET